Published: March 2014 Read Full-Text Guideline
This collaborative guideline considers several questions related to defining margins for patients who have reached breast-conserving surgery and WBI. It delineates when margins are positive and the necessary width to consider the margin negative. It also addresses the interaction between margin width and systemic therapy; biologic subtype; radiation therapy technique, fractionation and boost; invasive lobular carcinoma or lobular carcinoma in situ; and young age.
Developed in collaboration with:
Endorsed by:
Key Points:
Resources: Breast Cancer Refresher - 2017 (CME) Timing of RT and Chemo after BCS for Node-Positive Breast Cancer (CME) Patient Brochure
We have recently updated our privacy policy and terms of use. By using this site, you agree to ASTRO’s Privacy Policy and Terms of Use. We use cookies to provide, secure and improve our services to you. To learn more, click here.